Add to a list

Inactive Instrument

Encision Inc. Stock Other OTC

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

OTC Markets Traded

Encision Inc. is a medical device company. It designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include Product and Service. The Product segment designs, develops, manufactures and markets patented surgical instruments. The Service segment performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause tissue injury that may result in death. The AEM system consists of shielded 5mm AEM Instruments and an AEM monitor. Laparoscopic instruments have the integrated AEM design and include the full range of instruments that are common in laparoscopic surgery. The AEM monitor is compatible with electrosurgical generators.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	2.19M 1.92M 1.77M 1.66M 3.12M 207M 3.19M 21.31M 8.23M 102M 8.24M 8.06M 355M	P/E 2024	-12.5x	P/E 2025	-23.9x
Enterprise Value	3.25M 2.85M 2.62M 2.45M 4.62M 307M 4.72M 31.57M 12.2M 152M 12.21M 11.94M 526M	EV / Sales 2024	1.54x	EV / Sales 2025	1.03x
Free-Float	35.96%	Yield 2024 *	-	Yield 2025	-

12-13	Encision Inc. Announces Management Changes	CI
12-13	Encision Inc. Announces CEO Changes	CI
11-14	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-04	Encision Inc. Announces Resignation of Patrick Pace from Its Board of Directors, Effective October 30, 2025	CI
19/08/25	Encision Inc. announced that it has received $0.5 million in funding	CI
15/08/25	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
10/07/25	Encision Inc. Reports Earnings Results for the Full Year Ended March 31, 2025	CI
15/02/25	Encision Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
15/11/24	Earnings Flash (ECIA) ENCISION Reports Fiscal Q2 Revenue $1.8M	MT
15/11/24	Encision Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024	CI
14/08/24	Encision Inc. Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
15/07/24	Earnings Flash (ECIA) ENCISION Reports Q4 Revenue $1.5M	MT
15/07/24	Encision Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

05-04	Encision Inc. Announces Halt of Stock Trading	AQ
04-13	Encision Inc. Announces Fiscal 2026 Fourth Quarter and Full Year Results	AQ
01-30	Encision : Announces Decision to Deregister its Common Stock	PU
15/08/24	Encision : Reports First Quarter Fiscal Year 2025 Results Form 8 K	PU
23/10/23	Encision : Change in Certifying Accountants - Form 8-K	PU

Manager	Title	Age	Since
Robert Fries CEO	Chief Executive Officer	77	08/12/2025
Brandon Shepard DFI	Director of Finance/CFO	42	01/08/2024
Denise Baker LAW	General Counsel	-	01/01/2019

Director	Title	Age	Since
Vern Kornelsen BRD	Director/Board Member	93	01/01/1991
Robert Fries BRD	Director/Board Member	77	17/04/2024

Encision Inc. Stock Other OTC

Stocks

ECIA

US29254Q1040

Medical Equipment, Supplies & Distribution

Valuation: Encision Inc.

Latest news : Encision Inc.

Press Releases: Encision Inc.

Quotes and Performance

Managers and Directors: Encision Inc.

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ENCISION INC.	-5.88%	-7.25%	-	-	25.32K
ABBOTT LABORATORIES	-1.50%	+4.86%	-31.01%	-13.85%	164B
MEDTRONIC PLC	-0.06%	+2.00%	-5.92%	-6.29%	104B
CENCORA, INC.	-1.57%	+3.61%	-5.93%	+48.46%	55.67B
HOYA CORPORATION	+0.90%	-5.29%	+52.20%	+53.60%	52.92B
BECTON, DICKINSON AND COMPANY	-0.47%	+7.79%	-9.17%	-40.09%	42.96B
MEDLINE INC.	+1.90%	+10.21%	-	-	32.87B
DEXCOM, INC.	-0.23%	-3.44%	-18.94%	-44.64%	27.07B
WEST PHARMACEUTICAL SERVICES, INC.	+1.09%	+8.15%	+62.05%	-3.94%	24.79B
STERIS PLC	-1.13%	+5.25%	-10.70%	-1.68%	21.02B
Average	-0.50%	+3.81%	+4.07%	-1.05%	58.32B
Weighted average by Cap.	+0.12%	+3.98%	-5.81%	-0.92%

	2024	2025
Net sales	6.59M 5.77M 5.32M 4.97M 9.36M 623M 9.56M 63.95M 24.71M 307M 24.73M 24.19M 1.07B	6.56M 5.74M 5.29M 4.95M 9.31M 620M 9.52M 63.65M 24.6M 306M 24.62M 24.08M 1.06B
Net income	-692K -606K -558K -522K -983K -65.39M -1M -6.72M -2.6M -32.26M -2.6M -2.54M -112M	-220K -193K -178K -166K -313K -20.82M -320K -2.14M -826K -10.27M -827K -809K -35.65M
Net Debt	1.29M 1.13M 1.04M 974K 1.83M 122M 1.87M 12.53M 4.84M 60.19M 4.85M 4.74M 209M	1.06M 925K 853K 797K 1.5M 99.89M 1.53M 10.26M 3.96M 49.28M 3.97M 3.88M 171M